Valeo Pharma

(OTC) VPHIF

Current Price$0.00

Market CapN/A

Since IPO (2020)-100%

5 Year-100%

1 Year-100%

1 Month-99%

Valeo Pharma Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$53.38M

Net Income (TTM)

$32.12M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-5.15 (Low)

Dividend

$0.00

Beta (Volatility)

-5.15 (Low)

Price

$0.00

Volume

20,000

Open

$0.00

Price

$0.00

Volume

20,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Dividend

$0.00

Beta (Volatility)

-5.15 (Low)

Price

$0.00

Volume

20,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

VPHIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Valeo Pharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

125

CEO

Steven Saviuk, CPA

Website

www.valeopharma.com

Headquarters

Kirkland, QC H9H 4R9, CA

VPHIF Financials

Key Financial Metrics (TTM)

Gross Margin

24%

Operating Margin

-32%

Net Income Margin

-52%

Return on Equity

Return on Capital

-82%

Return on Assets

-67%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

Volume

20.00K

Avg. Volume

317.46

Financials (TTM)

Gross Profit

$13.08M

Operating Income

$17.23M

EBITDA

$11.39M

Operating Cash Flow

$15.70M

Capital Expenditure

$5.55M

Free Cash Flow

$21.25M

Cash & ST Invst.

$7.50M

Total Debt

$65.17M

Valeo Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$12.60M

-10.5%

Gross Profit

$3.43M

-19.6%

Gross Margin

27.25%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$8.19M

-40.3%

EBITDA

$3.68M

-109.7%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Net Cash

$62.96M

-15.9%

Accounts Receivable

$4.78M

-5.4%

Inventory

$4.94M

-61.7%

Long Term Debt

$24.43M

-61.8%

Short Term Debt

$45.65M

+64193.0%

Return on Assets

-67.48%

N/A

Return on Invested Capital

-82.30%

N/A

Free Cash Flow

$451.00K

+132.9%

Operating Cash Flow

$451.00K

+135.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LVCLFAlgorae Pharmaceuticals Limited

LVCLFAlgorae Pharmaceuticals Limited$0.01+0.00%

ALRTFALR Technologies Inc.

ALRTFALR Technologies Inc.$0.01-23.33%

LUFFFHerbal Dispatch Inc.

LUFFFHerbal Dispatch Inc.$0.05+5.08%

CHHEChina Health Industries Holdings, Inc.

CHHEChina Health Industries Holdings, Inc.$0.00+0.00%

TRUFFRed Light Holland Corp.

TRUFFRed Light Holland Corp.$0.03-0.68%

IMUCEOM Pharmaceuticals Holdings, Inc.

IMUCEOM Pharmaceuticals Holdings, Inc.$0.09+0.00%

HOOKHOOKIPA Pharma Inc.

HOOKHOOKIPA Pharma Inc.$1.19+1.28%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About VPHIF

What is the current price of Valeo Pharma?

Valeo Pharma is trading at N/A per share.

What is the 52-week range for Valeo Pharma?

Over the past 52 weeks, Valeo Pharma has traded between N/A and $0.05.

How much debt does Valeo Pharma have?

As of the most recent reporting period, Valeo Pharma reported total debt of $51.20M.

How much cash does Valeo Pharma have on hand?

Valeo Pharma reported $5.16M in cash and cash equivalents in its most recent financial results.

What is Valeo Pharma’s dividend yield?

Valeo Pharma does not currently have a dividend yield.

Valeo Pharma

Valeo Pharma Financials at a Glance

VPHIF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Valeo Pharma

VPHIF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Valeo Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VPHIF

What is the current price of Valeo Pharma?

What is the 52-week range for Valeo Pharma?

How much debt does Valeo Pharma have?

How much cash does Valeo Pharma have on hand?

What is Valeo Pharma’s dividend yield?

Premium Investing Services